Food retailers from supercenter operator Wal-Mart to the four-aisle stores of Aldi are grabbing for bigger shares of the consumer's food dollar with a new round of store expansions in the Indianapolis area.
At least 18 stores are under construction or planned, plus numerous store remodelings, at a construction tab that likely tops $200 million.
The surge in bricks-and-mortar investment is in response to a growing "foodie" culture, in which consumers shop more often, frequent multiple stores and increasingly search out gourmet, organic and other specialty items. At the same time, shoppers want low prices ��and reward stores that offer them ��forcing retailers to keep costs down even as they spend heavily on new stores.
Top 5 Freight Companies To Invest In 2015: Silicon Motion Technology Corporation(SIMO)
Silicon Motion Technology Corporation, a fabless semiconductor company, designs, develops, and supplies a portfolio of multimedia data processing, storage, and transfer solutions primarily for consumer electronics applications. The company offers a range of microcontrollers for use in NAND flash memory storage products, including flash memory cards, USB flash drives, and embedded flash and solid state drives. It also offers a range of multimedia SoCs comprising embedded graphics processors for embedded graphics applications in desktop and notebook personal computers, game consoles, work stations, and multimedia mobile phones. In addition, the company provides semiconductor solutions consisting of mobile television tuners and integrated tuner plus demodulator SoCs for mobile phones and other portable devices; and CDMA transceivers for CDMA 1x and EVDO modem solutions, as well as transceivers for LTE modem solutions. It sells its products to module makers, original equipment manufacturers, and original design manufacturers through its direct sales force and distributors in Canada, China, Europe, Japan, Korea, Taiwan, and the United States. The company is headquartered in Jhubei City, Taiwan.
Advisors' Opinion:- [By Garrett Cook]
Silicon Motion Technology (NASDAQ: SIMO) shares were also up, gaining 0.37 percent to $21.57 after the company raised its Q2 revenue forecast. The Company is expected to release its full Q2 results on July 28, 2014.
- [By Lisa Levin]
Silicon Motion Technology (NASDAQ: SIMO) surged 4.27% to $18.92. The volume of Silicon Motion Technology shares traded 315% higher than normal. Silicon Motion's PEG ratio is 0.95.
- [By Jake L'Ecuyer]
Silicon Motion Technology (NASDAQ: SIMO) was also up, gaining 14.72 percent to $17.07 after the company reported upbeat Q4 results and issued strong FY14 revenue forecast.
Top 5 Low Price Companies To Own In Right Now: Roche Holding AG (RHHBY)
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. The Company belongs to the Roche Group that operates through numerous subsidiaries and associated companies located around the world. The Company�� products and services cover every stage of the healthcare process, from identifying disease susceptibilities and testing for disease in at-risk populations to prevention, diagnosis, therapy and treatment monitoring. Roche operates through two divisions: Pharmaceuticals and Diagnostics. Within the Pharmaceuticals Division there are three sub-divisions: Roche Pharmaceuticals, Genentech and Chugai. The Company�� Diagnostics Division includes five sub-divisions: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. Its activities are structured into six geographical segments: North America; Asia-Pacific; Western Europe; Latin America; Central and Eastern Europe, Middle East and Africa (CEMAI), and Japan. In March 2009, the Company completed the acquisition of Genentech, Inc. In March 2010, the Company acquired assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow.
During the year ended December 31, 2008, the Company Pharmaceuticals Division marketing gained approvals for its rheumatoid arthritis medicine Actemra/RoActemra in Japan, Switzerland and the European Union. In 2008, the division initiated 12 new phase III projects in, including clinical trials of the compounds pertuzumab, for breast cancer; taspoglutide, for type two diabetes, and dalcetrapib, for cardiovascular risk reduction. As of December 31, 2008, the Pharmaceuticals Division filed 11 major new marketing applications and gained 13 major regulatory approvals. At the beginning of 2009, the division�� research and development pipeline comprised 120 clinical projects, including 62 new molecular entities (NMEs) and 58 additional indications. Forty NMEs are in phase I, 16 in phase II and six in phase III or f! iled for regulatory review.
In 2008, Roche Pharmaceuticals signed a total of 57 new agreements including seven product transactions and 43 research and technology collaborations. In May 2008, Roche acquired Piramed Limited, a UK company with therapeutic research programmes targeting the PI3-kinase pathway in oncology and inflammatory disease. In June 2008, signed licensing agreement with ThromboGenics and BioInvent for their jointly developed anticancer agent TB-403 (R7334). In September, 2008, the Company acquired Mirus Bio Corporation active in the field of ribonucleic acid interference (RNAi) delivery and completed the acquisition of ARIUS Research Inc., which has a antibody platform that identifies and selects antibodies based on their functional ability to affect disease. S Research Inc. In January 2009, Roche acquired Memory Pharmaceuticals, which develops drug candidates for the treatment of debilitating central nervous system disorders such as Alzheimer�� disease and schizophrenia.
Pharmaceuticals
Within Pharmaceuticals division, the Company is engaged in the provision of drugs the areas of oncology, anemia, cardiovascular diseases, central nervous system, infectious diseases, inflammatory and autoimmune diseases, metabolic disorders, cancer, transplantation and virology. The products offered by Roche�� Pharmaceuticals division include MabThera/Rituxan, Herceptin, Avastin, Tamiflu, CellCept, NeoRecormon, Epogin, Pegasys, Tarceva, Xeloda, Bonviva, Boniva, Lucentis, Tamiflu, Xolair, Valcyte, Cymevene, Xenical, Pulmozyme, Nutropin, Neutrogin, Rocephin, Activase, TNKase and Madopar. The products offered by the Pharmaceuticals division are sold in seven geographic regions: North America; Asia-Pacific; Western Europe; Latin America; Central and Eastern Europe, Middle East and Africa (CEMAI), and Japan.
Diagnostics
Roche�� Diagnostics Division is a supplier of in vitro diagnostics (IVDs). Its products are used to test body fluids a! nd tissue! samples to obtain information for the purpose of preventing, diagnosing, treating and monitoring disease. The Company has business areas five within the diagnostics division: Professional Diagnostics, Diabetes Care, Tissue Diagnostics, Molecular Diagnostics and Applied Science. Roche�� Diagnostics division provides IVD services, including centralized laboratory testing and point-of-care diagnostics to molecular diagnostics and diabetes self management. In addition, it supplies research tools to life scientists.
Roche Professional Diagnostics supplies instrument systems, tests, software and services. It provides point-of-care testing products to support clinical decision-making close to the patient, in doctors��offices, emergency rooms and other primary and specialty care settings. Twelve Serum Work Area assays were rolled out during the year ended December 31, 2008, across Europe and in other markets. New assays included the Elecsys anti-TSH receptor antibody assay for the diagnosis of Graves��disease the Elecsys anti-CCP antibody assay, a test to aid the diagnosis of rheumatoid arthritis, and the Roche Cystatin C clinical chemistry test for early detection of impaired kidney function, among others. Roche Diabetes Care�� products portfolio covers the entire diabetes self-management spectrum, from glucose monitoring to insulin delivery, as well as monitoring systems with integrated lancets and test strips software for storing and analyzing data. Roche Tissue Diagnostics develops and manufactures medical diagnostic instruments and reagent systems that provide automation technology for use in the diagnosis and prognosis of cancer and infectious disease. In 2008 Roche Tissue Diagnostics launched ofhe Bench- Mark Ultra, a system that performs immunohistochemistry and in situ hybridisation testing simultaneously on a single continuous and random access platform. Roche Molecular Diagnostics develops and commercializes diagnostic and blood screening platforms and tests based on Roche�� ! real-time! polymerase chain reaction (PCR) technology. Applied Science business area supplies a specific reagents and test kits for use in life sciences encompassing biology, biotechnology ,medical research, as well as disease areas like cancer and virology. Applied Science�� business area product portfolio includes such sequencing systems as LightCycler 480, LightCycler 480 II, GS FLX Titanium. In addition, Applied Science offers xCELLigence cell analyzer.
Advisors' Opinion:- [By Ben Levisohn]
Shares of InterMune (ITMN) have jumped 36% to $73.40�after�Roche�(RHHBY) said it would buy the drug maker for $8.3 billion.
Burger King Worldwide�(BKW) has climbed 7.9% to $29.25�on reports that the hamburger joint is considering the purchase of Canadian coffee-outlet Tim Hortons�(THI) for the tax benefits. Tim Hortons has gained 15% to $72.00.
- [By Monica Gerson]
BioMarin Pharmaceutical (NASDAQ: BMRN) shares moved up 1.48% to $78.64. The volume of BioMarin Pharmaceutical shares traded was 966% higher than normal. BioMarin shares jumped on Roche Holding (OTC: RHHBY) takeover report..
- [By James Brumley]
Ditto for the gene-mapping mania that was sparked by the Roche (RHHBY) acquisition of Illumina and the GlaxoSmithKline (GSK) purchase of Human Genome Sciences. By the time the gene-mapping M&A trend became obviously hot, the trend was over.
Top 5 Low Price Companies To Own In Right Now: Range Resources Corporation(RRC)
Range Resources Corporation, an independent natural gas company, engages in the acquisition, exploration, and development of natural gas properties primarily in the Appalachian and southwestern regions of the United States. The company?s Appalachian region drilling and producing activities include tight-gas, shale, coal bed methane, and conventional natural gas and oil production in Pennsylvania, Virginia, Ohio, and West Virginia. It owns 4,969 net producing wells, approximately 2,750 miles of gas gathering lines, and approximately 1.8 million gross acres under lease. The company?s Southwestern drilling and producing activities cover the Barnett Shale of North Texas, the Permian Basin of West Texas and eastern New Mexico, the East Texas Basin, the Texas Panhandle, and the Anadarko Basin of Western Oklahoma. It owns 1,954 net producing wells, as well as approximately 886,000 gross acres under lease. As of December 31, 2010, Range Resources Corporation had had 4.4 Tcfe of pr oved reserves. It sells gas to utilities, marketing companies, and industrial users. The company was formerly known as Lomak Petroleum, Inc. and changed its name to Range Resources Corporation in 1998. Range Resources Corporation was founded in 1975 and is headquartered in Fort Worth, Texas.
Advisors' Opinion:- [By Chad Fraser]
This started to change in 2004, when Range Resources (NYSE: RRC)—one of the Marcellus shale stocks we’ll look at below—began extracting gas from the shale rock using horizontal drilling and hydraulic fracturing.
- [By Doug Ehrman]
The report
The group bases its report on how much natural gas it believes is recoverable in the U.S. using only currently available technologies, but ignoring any cost constraints that might act as a disincentive to the actual recovery of the supply. The boom in hydraulic fracturing ��more commonly referred to as fracking ��is primarily responsible to the increase. Geographically, the Marcellus Shale, stretching from New York across Pennsylvania to Ohio, has been at the center of the supply glut. Both Chesapeake and Range Resources (NYSE: RRC ) have large holdings in the area. Range Resources has faced far fewer non-natural-gas setbacks than Chesapeake ��specifically, Range did not suffer from the misbehavior of its CEO ��and its stock is up nearly 50% over the last two years. The fates of different natural gas stocks have been very company-specific of late.
Top 5 Low Price Companies To Own In Right Now: QLogic Corporation(QLGC)
QLogic Corporation engages in the design and supply of storage networking, high performance computing networking, and converged networking infrastructure solutions. It offers various host products, including fiber channel and Internet small computer systems interface (iSCSI) host bus adapters; fiber channel over Ethernet (FCoE) converged network adapters; and intelligent Ethernet adapters. The company also provides network products, which consist of fiber channel switches, including stackable edge switches, bladed switches, virtualized pass-through modules, and high-port count modular-chassis switches; Ethernet pass-through modules; and storage routers for bridging fiber Channel, FCoE, and iSCSI networks, as well as for migrating data between storage devices. In addition, it offers silicon products comprising fiber channel, iSCSI, converged network, and Ethernet controllers. Further, the company involves in the design and development of application-specific integrated circ uits, adapters, and switches based on fiber channel, iSCSI, FCoE, and Ethernet technologies. Its products are used in server, workstation, and storage subsystem solutions that are used by small, medium, and large enterprises with various business data requirements. The company sells its products to original equipment manufacturers and distributors worldwide. QLogic Corporation was founded in 1992 and is headquartered in Aliso Viejo, California.
Advisors' Opinion:- [By Sean Williams]
Also in the news ...
Let's not sugarcoat this one iota: It was a really busy week for earnings news, with network equipment maker QLogic (NASDAQ: QLGC ) , printing and IT specialist Xerox (NYSE: XRX ) , and telecommunication services provider Orange (NYSE: ORAN ) all reporting results.
No comments:
Post a Comment